NV-Thyro 0.1 mg Tablet is a Health Canada–registered veterinary drug (DIN 02238429) held by Novopharm Limited, containing Levothyroxine Sodium. Health Canada lists its status as Cancelled Post Market (status date 26 Oct 2015). Nexara Health has matched 1799 registrations of Levothyroxine Sodium across 31 other regulated markets, 47 of them in the same strength and dosage form.

Health Canada registration

Levothyroxine Sodium registered in other markets

1799 registrations of the same molecule in 31 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Levothyroxine Sodium worldwide →

Regulator price references for Levothyroxine Sodium

Published list or reimbursement prices for Levothyroxine Sodium presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is NV-Thyro (DIN 02238429) marketed in Canada?

No. Health Canada lists DIN 02238429 as Cancelled Post Market as of 26 Oct 2015.

Who holds the Canadian licence for this product?

Novopharm Limited is the company of record in the Health Canada Drug Product Database.

Is Levothyroxine Sodium registered outside Canada?

Yes — Nexara Health has matched 1799 registrations in 31 other markets, including 47 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02238429, status date 2015-10-26; national medicine registries: ANMDMR nomenclator, ARCSA registro sanitario, BDA, CMED, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EU national register, HSA, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NHRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CMED, EDE, eEKO (Erstattungskodex), NHRA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02238429, status date 2015-10-26; national medicine registries: ANMDMR nomenclator, ARCSA registro sanitario, BDA, CMED, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EU national register, HSA, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NHRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CMED, EDE, eEKO (Erstattungskodex), NHRA, PBS.

Health Canada Drug Product Database (DPD), DIN 02238429, status date 2015-10-26; national medicine registries: ANMDMR nomenclator, ARCSA registro sanitario, BDA, CMED, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EU national register, HSA, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NHRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CMED, EDE, eEKO (Erstattungskodex), NHRA, PBS. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.